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OBJECTIVE—To study the association between adherence to the Mediterranean dietary pat-
tern (MDP) and risk of developing type 2 diabetes, across European countries.
RESEARCH DESIGN ANDMETHODS—We established a case-cohort study including
11,994 incident type 2 diabetic case subjects and a stratiﬁed subcohort of 15,798 participants
selected from a total cohort of 340,234 participants with 3.99 million person-years of follow-up,
from eight European cohorts participating in the European Prospective Investigation into Cancer
and Nutrition (EPIC) study. The relative Mediterranean diet score (rMED) (score range 0–18)
was used to assess adherence to MDP on the basis of reported consumption of nine dietary
components characteristic of theMediterranean diet. Cox proportional hazards regression, mod-
iﬁed for the case-cohort design, was used to estimate the association between rMED and risk of
type 2 diabetes, adjusting for confounders.
RESULTS—The multiple adjusted hazard ratios of type 2 diabetes among individuals with
medium (rMED 7–10 points) and high adherence to MDP (rMED 11–18 points) were 0.93 (95%
CI 0.86–1.01) and 0.88 (0.79–0.97), respectively, compared with individuals with low adher-
ence to MDP (0–6 points) (P for trend 0.013). The association between rMED and type 2 diabetes
was attenuated in people,50 years of age, in obese participants, andwhen the alcohol, meat, and
olive oil components were excluded from the score.
CONCLUSIONS—In this large prospective study, adherence to the MDP, as deﬁned by
rMED, was associated with a small reduction in the risk of developing type 2 diabetes in this
European population.
Diabetes Care 34:1913–1918, 2011
The Mediterranean dietary pattern(MDP) is characterized by a high con-sumption of unreﬁned cereals, fruits,
vegetables, olive oil, and legumes; a mod-
erate consumption of dairy products
(mostly cheese and yogurt); moderate wine
consumption; a moderate-to-high con-
sumption of ﬁsh; and a low consumption
of meat and meat products (1,2). Numer-
ous epidemiological studies have assessed
adherence to the MDP through a priori de-
ﬁned scores or indexes and have linked it to
reduced chronic disease morbidity and
mortality (3). The MDP has also been pos-
tulated as an effective diet for the preven-
tion and treatment of type 2 diabetes (4,5).
However, epidemiological evidence for an
association between MDP and type 2 dia-
betes is limited. Two previous observa-
tional prospective studies (6,7) and one
intervention study (8) found that higher
adherence to the MPD was associated
with a lower risk of developing type 2 di-
abetes.However, previous studies included
small samples mostly consisting of at-risk
individuals from Mediterranean popula-
tions, limiting generalizability to the gen-
eral population.
The objective of our studywas to assess
the association between adherence to the
MDP, using an a priori deﬁned score, and
incidence of type 2 diabetes among a large
European population including Mediter-
ranean and non-Mediterranean countries,
with diversity of dietary patterns. We tried
to overcome the methodological limita-
tions of previous studies by ascertaining a
large number of incident-veriﬁed diabetic
case subjects in a cohort of apparently
healthy participants at baseline, removing
the problem of recall bias. The size of the
study provides sufﬁcient power to study
the effect of multiple potential confound-
ers, effect modiﬁers, and plausible medi-
ators of the association between diet and
type 2 diabetes, as well as to investigate
the relative importance of the individual
components of the MDP on type 2 di-
abetes risk.
RESEARCH DESIGN AND
METHODS
Study population
Between 1992 and 2000, 521,448 ap-
parently healthy volunteers aged be-
tween 25 and 70 years were recruited
in 23 centers from 10 European countries
(Denmark, France, Germany, Greece, Italy,
the Netherlands, Norway, Spain, Sweden,
and the U.K.) participating in the European
Prospective Investigation into Cancer and
Nutrition (EPIC) study. Approval for this
study was obtained from the ethical review
boards of the International Agency for Re-
search on Cancer and from all local institu-
tions where participants had been recruited
for the EPIC study. Written informed con-
sent was obtained from all participants be-
fore joining the EPIC study. Details of the
recruitment and study design have been
published elsewhere (9–11).
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The InterAct Consortium was initi-
ated to investigate how genetic and life-
style factors interact in their inﬂuence on
the risk of developing type 2 diabetes
(12). InterAct partners ascertained and
veriﬁed incident type 2 diabetic case sub-
jects occurring in the EPIC cohort. With
the exception of Norway and Greece, all
EPIC countries participated in the Inter-
Act project (n = 455,680). Individuals
without stored blood (n = 109,625) or
with prevalent diabetes status at baseline
(n = 5,821) were not eligible for InterAct.
Type 2 diabetes case ascertainment
and veriﬁcation
We designed a pragmatic high-sensitivity
approach for case ascertainment aimed at
identifying potential incident diabetic
case subjects and excluding individuals
with known prevalent diabetes, using at
least two multiple sources of evidence in-
cluding self-report, linkage to primary or
secondary care registers, drug registers,
hospital admissions, and mortality data.
Cases in Denmark and Sweden were not
ascertained by self-report but were iden-
tiﬁed via local and national diabetes and
pharmaceutical registers. Follow-up was
censored on 31 December 2007 or the
date of death, whichever occurred earlier.
In total, 12,403 veriﬁed incident type 2
diabetic case subjects were identiﬁed.
The date of diagnosis for incident case
subjects was set as either the date of diag-
nosis reported by the doctor, the earliest
date that diabetes was recorded in med-
ical records, the date of inclusion into the
diabetes registry, the date reported by the
participant, or the date of the question-
naire in which diabetes was ﬁrst reported.
If the date of diagnosis could not be as-
certained from any of the sources listed
above, the midpoint between recruitment
and censoring was used (12).
Case-cohort construction
The case-cohort study included a random
subcohort of 16,835 individuals selected
from those with available stored blood
samples, stratiﬁed by center.We oversam-
pled for the proportion of prevalent type
2 diabetic case subjects in each center
with the aim that, by center, the number
of individuals in the subcohort (after later
exclusion of individuals with prevalent
diabetes) should be approximately similar
to the number of incident case subjects.
After exclusion of 548 individuals with
prevalent diabetes and 133 with unknown
diabetes status, 16,154 subcohort individ-
ualswere included in the analysis, ofwhom
778 had developed incident type 2 diabetes
during follow-up. An overlap between the
case set and the subcohort is a design fea-
ture of a case-cohort study.
Dietary assessment and
Mediterranean diet score
Usual food intake was estimated using
country-speciﬁc validated dietary ques-
tionnaires (13). Estimated individual nu-
trient intakes were derived from foods
included in the dietary questionnaires
through the standardized EPIC Nutri-
ent Database (ENDB) (14). Participants
within the lowest and highest 1% of the
cohort distribution of the ratio of reported
total energy intake:energy requirement
were excluded from the current study
(n = 736).
Adherence to MDP was assessed us-
ing the relative Mediterranean diet score
(rMED) (15), a variation of the original
Mediterranean diet score (1,2). This score
included nine nutritional components
characteristic of the MDP: some poten-
tially beneﬁcial components (vegetables,
legumes, fruits and nuts, cereals, ﬁsh and
seafood, olive oil, and moderate alcohol
consumption) and other potentially det-
rimental components (meat and meat
products and dairy products). Each
rMED component (apart from alcohol)
was measured as grams per 1,000 kcal
(16). All components of the score (except
for olive oil and alcohol, as described be-
low) were divided into tertiles of dietary
intake, according to the distribution ob-
served in the overall subcohort. A value of
0, 1, and 2 was assigned to the ﬁrst, sec-
ond, and third tertiles, respectively, of the
intakes of the beneﬁcial components. The
scoring was reversed for the two presum-
ably detrimental components. The scor-
ing for olive oil was modiﬁed because of
the relatively large number of noncon-
sumers. Therefore, 0 was assigned to non-
consumers, 1 for participants with an
intake below the median olive oil con-
sumption (calculated only within olive
oil consumers), and 2 for people whose
intake was equal or above this median.
For alcohol, a value of 2 was given to
those with moderate alcohol consump-
tion (ethanol intakes from 10 to ,50
g/day inmen and5 and25 g/day inwomen)
and a value of 0 otherwise. Therefore, the
rMED ranged from 0 (indicating the low-
est adherence to theMDP) to 18 (the high-
est adherence to the MDP). The rMEDwas
further classiﬁed in categories to reﬂect
low (0–6 points), medium (7–10 points),
or high (11–18 points) adherence to the
MDP on the basis of previously published
cutoff points (15).
Assessment of other covariates
Standard questionnaires were used to
collect information on the participants’
sociodemographic characteristics and
lifestyle variables (9). For the current
study, we used information about smok-
ing status (never-smoker, former smoker,
and current smoker) and number of cig-
arettes smoked per day (1–10, 11–20,
and.20 cigarettes/day); educational level
(no formal education, primary school,
technical school, secondary school, and
university degree); and an ordered four-
category index of physical activity (17).
Weight, height, waist circumference
(WC), and hip circumference were ob-
tained at baseline using standardized
protocols (18). BMI was calculated as
weight in kilograms divided by squared
height in meters (kg/m2).
In most participating centers, informa-
tion on the presence of chronic conditions
at baselinewas collected, i.e., hypertension,
hyperlipidemia, and previous cardiovascu-
lar disease (angina, stroke, and myocardial
infarction). Information on family history
of type 2 diabetes in a ﬁrst-degree relative
was collected for all participants except for
individuals in Italy, Spain, Germany, and
Oxford.
Statistical analysis
Cox proportional hazards regression,
modiﬁed for the case-cohort design ac-
cording to the Prentice method (19), was
used to estimate the association between
rMED and risk of type 2 diabetes. Age was
used as the underlying time scale, with
entry time deﬁned as the participant’s
age at recruitment and exit time as age at
diagnosis of diabetes, censoring, or death
(whichever came ﬁrst). All analyses were
stratiﬁed by center to control for center
effects such as follow-up procedures and
questionnaire design.
We evaluated the shape of the asso-
ciation of rMED with type 2 diabetes risk
by using restricted cubic splines with ﬁve
knots placed at the 5th, 25th, 50th, 75th,
and 95th percentile of rMED distribution,
which showed no evidence of departure
from linearity. The rMED score was then
assessed as a continuous variable (two-
point increment) and as a categorical
variable (low, medium, and high adher-
ence to the MDP). The rMED categorical
variable was scored from 1 to 3, and trend
tests were calculated on these scores.
Different models were used, with different
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levels of adjustment: ﬁrst, a crude model
was run; then the model was further ad-
justed for sex and BMI; and ﬁnally we ran a
multiple adjusted model that also included
educational level, smoking status, physical
activity, and total energy intake. Therewere
some participants with missing values
for physical activity (n = 382, 1.41% of
the sample), educational level (n = 235,
0.87%), and smoking status (n = 247,
0.91%). We treated participants with
missing data as a separate category for
these three variables.
We evaluated the relative importance
of each of the components of rMED on
type 2 diabetes risk by subtracting one
component at a time from the original
score, as previously reported (20).
Effect modiﬁcations by sex, age-
group (,50, 50–59, and $60 years),
baseline BMI category (BMI ,25, 25 to
,30, and $30 kg/m2), smoking status
(former smokers, current smokers, and
never-smokers), and history of diabetes
in a ﬁrst-degree relative were assessed by
modeling interaction terms between these
variables and rMED and conducting strat-
iﬁed analyses.
To ascertain whether the association
between MDP and diabetes risk was medi-
ated through speciﬁc risk factors, models
were additionally adjusted for WC (after
excluding participants in Umea, Sweden,
where WC was not measured; n = 1,796),
hyperlipidemia (after excluding partici-
pants in Umea and Malmo, Sweden, where
hyperlipidemia was not reported; n =
5,272), and hypertension (individually and
simultaneously). Sensitivity analyses were
performed excluding participants with car-
diovascular disease at baseline (myocardial
infarction, stroke, and angina), self-reported
hypertension, self-reported hyperlipid-
emia, and obesity (BMI $30 kg/m2); ex-
cluding the ﬁrst 2 years of follow-up; and
excluding mis-reporters of energy (both
under-reporters [individuals with a ratio of
energy intake:basal metabolic rate, or EI:
BMR, ,1.14] and over-reporters [EI:BMR
.2.1], based on the cutoff points proposed
by Goldberg et al. [21]). A calibrated ver-
sion of the rMED correcting for any system-
atic under- or overestimation of dietary
intake among countries was constructed
on the basis of a calibration study in a ran-
dom subsample of EPIC using a detailed
computerized 24-h dietary recall (14).
Dietary exposures across countries were
scaled using an additive calibration (13).
Finally, heterogeneity among countries in
the association between rMED and type 2
diabetes risk was assessed by calculating
country-speciﬁc estimates and using
random-effect meta-analyses (I2).
All statistical analyses were per-
formed with SAS software, version 9.1
(SAS Institute, Cary, NC) and STATA
10.0 (StataCorp, College Station, TX).
RESULTS—After exclusions, 11,994 in-
cident type 2 diabetic case subjects were
identiﬁed and a subcohort of 15,798 was
selected (including an overall of 749 di-
abetic case subjects). Information on the
distribution of case subjects and charac-
teristics of the sample by country are in
Supplementary Table A1. Table 1 shows
the sociodemographic, anthropometric,
lifestyle, and health characteristics of the
subcohort by category of the rMED.
The crude hazard ratios (HRs) for
type 2 diabetes in the medium and high
category of the score were 0.74 (95% CI
0.70–0.79) and 0.65 (0.60–0.71), respec-
tively, compared with the lowest category
(P for trend , 0.0001). These risk esti-
mates were attenuated after adjustment
for confounders; adjusted HRs for diabe-
tes were 0.93 (0.86–1.01) in the medium
category and 0.88 (0.79–0.97) in the high
category of rMED (P for trend 0.013).
Overall, in the multiple adjusted model, a
two-point increment in rMED was associ-
ated with a 4% (1–6) reduction in the risk
of type 2 diabetes (Table 2).
The contribution of each component
of rMED on diabetes risk was assessed by
sequential subtraction of components
from the score (Supplementary Table A2).
The association of rMED with diabetes
risk was attenuated after excluding the al-
cohol (HR 0.98, 95% CI 0.95–1.01), meat
(0.98, 0.95–1.00), and olive oil (0.97,
0.95–1.00) components.
Results of the stratiﬁed analyses by sex,
age-group, baseline BMI category, smoking
status, and history of diabetes are shown in
Table 3. There was evidence of effect mod-
iﬁcation by age-group (P for interaction
0.019). No association between rMED
and diabetes was observed among the
youngest participants (,50 years of age).
Although the interaction was not statisti-
cally signiﬁcant, the association between
rMED and diabetes risk was stronger
among normal-weight participants, never-
smokers, and individuals without a family
history of type 2 diabetes.
The effect estimate of rMED on di-
abetes risk did not change after further
adjustment for hyperlipidemia, hyper-
tension, and WC (both individually and
simultaneously). The association between T
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rMED and diabetes risk was similar after
excluding the ﬁrst 2 years of follow-up or
participants with chronic disease at base-
line (myocardial infarction, stroke, angina,
hypertension, hyperlipidemia, or obesity).
The association was slightly strengthened
when both sets of exclusion were applied
simultaneously. The association between
rMED and diabetes risk was unchanged
when the components of the score were
calibrated using additive calibration and
when mis-reporters of energy were ex-
cluded (Supplementary Table A3).
Country-speciﬁc HRs and pooled
HRs for type 2 diabetes associated with a
two-point increment in rMED are shown
in Supplementary Fig. A1. There was evi-
dence of heterogeneity in the association
between countries (I2 59%, P for hetero-
geneity 0.012). The pooled HR estimate
obtained using random-effect meta-
analyses was 0.93 (95% CI 0.89–0.98;
P = 0.001). In post hoc meta-regression
analyses to examine possible explanations
for the observed heterogeneity, mean age
was the only variable related to the country-
speciﬁc estimate of the association between
MDP and incident diabetes (P = 0.019)
(Supplementary Fig. A2).
CONCLUSIONS—In this large Euro-
pean case-cohort study, higher adherence
to the MDP as deﬁned by rMED was
associated with a lower risk of developing
type 2 diabetes. Individuals with a high
rMED score range (11–18 points) were
12% (95% CI 3–21) less likely to develop
diabetes than individuals with low rMED
scores (0–6 points). The alcohol, meat,
and olive oil components of the rMED
accounted for most of the observed
association.
Strengths of this study include the
large sample size of healthy individuals at
baseline, from which we ascertained a
large number of veriﬁed incident cases of
type 2 diabetes during 4 million person-
years of follow-up. We also included both
Mediterranean and non-Mediterranean
countries and were able to control for a
large number of plausible confounders,
effect modiﬁers, and factors that may lie
in the etiological pathway of the associa-
tion between MDP and type 2 diabetes.
Our limitations include the use of a clin-
ical deﬁnition of incident type 2 diabetes
not based on glucose measurement. It is
possible that we did not identify individ-
uals who became biochemically diabetic
during follow-up but who did not come
to clinical recognition. However, this
would only be an issue for the estimation
of association with a baseline factor if that
factor was itself linked to the likelihood of
being tested for diabetes during follow-
up. This would not be the case of the
Mediterranean diet. We excluded known
cases of diabetes at baseline but did not
screen the entire cohort to exclude people
who had prevalent but clinically unrec-
ognized disease. The focus on the exclu-
sion of clinically recognized cases was to
avoid the issues of recall bias of expo-
sures, where reporting would have been
affected by the diagnosis of diabetes. The
presence of a small proportion of preva-
lent but unrecognized cases of diabetes
among the control cohort would have a
negligible effect on the measure of asso-
ciation. Diet and other lifestyle variables
were assessed once at baseline. Therefore,
changes in lifestyle could not be taken
into account in these analyses. Validated
country-speciﬁc dietary questionnaires
were used to assess usual dietary intake.
To try to limit measurement error and
reporting bias, we constructed a calibra-
ted version of the rMED and repeated the
analyses after excluding plausible mis-
reporters of energy intake, with no ap-
parent change in results. Our ﬁndings
might be explained by reverse causality
if changes in diet occurred after being
diagnosed with a chronic disease; in-
deed, the association between rMED and
diabetes risk was slightly strengthened
after excluding participants with chronic
diseases at baseline and those develop-
ing diabetes within the ﬁrst 2 years of
follow-up.
Two previous observational prospec-
tive studies have evaluated the association
between theMDP and new-onset of type 2
diabetes, one of which included highly
educated individuals from Spain with
only 33 incident diabetic case subjects
(6). The other included Italian recent
myocardial infarction patients (998 inci-
dent diabetic case subjects) (7). In both of
these studies, a higher Mediterranean diet
score predicted a lower risk of subsequent
development of type 2 diabetes. The small
sample size of the Spanish study and the
selected nature of the Italian population
limit the conclusions that can be drawn
from these data. However, the results are
generally consistent with those of the cur-
rent study, which included a much larger
sample size of apparently healthy par-
ticipants from eight European countries.
A recent randomized controlled trial
Table 3—Multiple adjusted HRs of type 2 diabetes associated with a two-point
increment in the rMED in population subgroups
Number of cases/
number of subcohort* HR† 95% CI
P for
interaction‡
Sex 0.144
Male 5,946/5,597 0.96 0.93–1.00
Female 5,670/9,452 0.95 0.91–0.98
Age (years) 0.019
,50 2,637/5,681 1.00 0.94–1.06
50–59 5,604/6,119 0.95 0.91–0.98
$60 3,753/3,249 0.96 0.92–1.00
BMI (kg/m2) 0.088
,25 1,666/6,936 0.92 0.88–0.97
25–29 5,266/5,987 0.95 0.92–0.98
$30 5,062/2,126 0.99 0.95–1.03
Smoking status 0.393
Never 4,882/7,038 0.95 0.92–0.99
Former 3,716/4,038 0.97 0.92–1.01
Current 3,295/3,827 0.96 0.92–1.01
History of diabetes in a
ﬁrst-degree relative§ 0.527
No 3,441/5,474 0.92 0.88–0.96
Yes 1,935/1,138 0.96 0.90–1.04
*Numbers in the subcohort exclude type 2 diabetic case subjects. †Modiﬁed Cox proportional hazards re-
gressionmodels stratiﬁed by center and adjusted for sex, BMI (as a continuous variable), educational level (no
formal education, primary school, technical/professional school, secondary school, and longer education
including university degree), physical activity (inactive, moderately inactive, moderately active, and active),
smoking status (never, former, and three categories of current smoker: 1–10 cigarettes day21, 11–20 ciga-
rettes day21, and.20 cigarettes day21), and total calorie intake (as a continuous variable). ‡Heterogeneity
among subgroups was tested by adding an interaction term in the model between these variables and rMED.
§Family history of diabetes was not ascertained in the centers in Italy, Spain, Germany, and Oxford.
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conducted among elderly people from
Spain with cardiovascular risk factors
showed that a non–energy-restricted tra-
ditional Mediterranean diet supplemented
with either olive oil or nuts reduced the risk
of developing type 2 diabetes, compared
with a low-fat diet (8). However, this trial
was limited by the supplementation of both
Mediterranean diets with sources of unsat-
urated fatty acids. It is uncertain if the ob-
served association was related to the
Mediterranean diet per se, or to the supple-
mentation with unsaturated fat.
We observed a similar HR for type 2
diabetes risk when a random-effect meta-
analysis was used to pool country-speciﬁc
estimates, but found evidence of country
heterogeneity in the association between
rMED and type 2 diabetes risk. In a meta-
regression analysis, mean age was the only
variable related to the country-speciﬁc
estimates of the association between MDP
and diabetes risk. Countries with average
older ages in their cohorts (France, U.K.
[general population], and Denmark) ten-
ded to show stronger associations between
MDP and diabetes risk. This is consistent
with our ﬁnding of effect modiﬁcation by
age-group. We found no other signiﬁcant
interactions, but there was a nonsigniﬁcant
tendency for the association to be stronger
among the older nonobese never-smokers
and individuals without family history of
type 2 diabetes.
In conclusion, the results of this large
case-cohort study show that adherence to
theMDP, as deﬁned by rMED, is associated
with a small reduction in the risk of de-
veloping type 2 diabetes in this European
population. These results highlight the
potential of eating a healthy dietary pattern
in the prevention of type 2 diabetes.
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